The Role of an Activatable Esterase in Immune-Dependent Phagocytosis by Human Neutrophils
Open Access
- 1 April 1977
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 118 (4) , 1354-1365
- https://doi.org/10.4049/jimmunol.118.4.1354
Abstract
Diisopropylphosphofluoridate, cyclohexyl alkylphosphonofluoridates, and cyclohexyl phenylalkylphosphonofluoridates, which are potent, irreversible inactivators of serine esterases, inhibit the phagocytosis of opsonized sheep erythrocytes by human neutrophils. Two types of inhibition were observed: a) “cell-dependent” inhibition, which is determined by measuring the ingestion of neutrophils pretreated with the esterase inhibitors and washed; and b) “phagocytosis-dependent” inhibition, which is due to the presence of the inhibitors during phagocytosis. With the cyclohexyl alkylphosphonofluoridates, phagocytosis-dependent inhibition was always greater than cell-dependent inhibition. Cell-dependent inhibition was irreversible and dependent on the duration of the incubation of neutrophils with inhibitor. Both types of inhibition were dependent on the concentration of the inhibitor. Poorly or non-phosphorylating analogues of the cyclohexyl alkylphosphonofluoridates of DFP were not inhibitory; nor did fluoride, the hydrolysis product of these inhibitors, inhibit ingestion under either condition. In addition, neither method of treating the neutrophils resulted in a decrease in neutrophil viability. Furthermore, pretreating the EAC1423 with the inhibitors did not decrease ingestion. We conclude that cell-dependent inhibition is due to the inactivation of an esterase required for phagocytosis which is in or on the neutrophil in an active form, and thus is susceptible to inhibition by the esterase inactivators before contact of the neutrophil with the phagocytic stimulus. Phagocytosis-dependent inhibition is interpreted as being due to inactivation of an esterase required for phagocytosis which is normally in an inactive precursor proesterase form that is activated by the interaction of the neutrophil with the phagocytic stimulus. The distinctly different inhibition profiles of the active and activatable esterases indicate that they are two different activities.This publication has 14 references indexed in Scilit:
- The relationship of the structure of phosphonate esters to their ability to inhibit chymotrypsin, trypsin, acetylcholinesterase and C′iaBiochimica et Biophysica Acta (BBA) - Protein Structure, 1967
- MECHANISMS OF THE INHIBITION OF CHEMOTAXIS BY PHOSPHONATE ESTERSThe Journal of Experimental Medicine, 1967
- PARTIAL BIOCHEMICAL CHARACTERIZATION OF THE ACTIVATED ESTERASE REQUIRED IN THE COMPLEMENT-DEPENDENT CHEMOTAXIS OF RABBIT POLYMORPHONUCLEAR LEUKOCYTESThe Journal of Experimental Medicine, 1967
- MECHANISMS OF IMMUNOLOGIC INJURY OF RAT PERITONEAL MAST CELLSThe Journal of Experimental Medicine, 1966
- Reaction of Ficin with Diisopropylphosphorofluoridate. Evidence for a Contaminating Inhibitor*Biochemistry, 1965
- A COMPARISON OF THE SPECIFICITY OF INHIBITION BY PHOSPHONATE ESTERS OF THE FIRST COMPONENT OF COMPLEMENT AND THE ANTIGEN-INDUCED RELEASE OF HISTAMINE FROM GUINEA PIG LUNGThe Journal of Experimental Medicine, 1964
- Enzyme inhibitory activity of certain phosphonate esters against chymotrypsin, trypsin and acetylcholinesteraseBiochimica et Biophysica Acta (BBA) - Specialized Section on Enzymological Subjects, 1964
- The Relationship of Enzyme Inhibitory Activity to the Structure of n-Alkylphosphonate and Phenylalkylphosphonate Esters*Biochemistry, 1963
- The Biochemical Basis of PhagocytosisJournal of Biological Chemistry, 1959
- Relative Specificity of Serologic Tests for Syphilis inMycobacterium LepraeInfectionAmerican Journal of Clinical Pathology, 1957